ARCT-021 Dose 1
ARCT-021-01
Phase 2 mab completed
Quick answer
ARCT-021 Dose 1 for SARS-CoV-2 is a Phase 2 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- SARS-CoV-2
- Phase
- Phase 2
- Modality
- mab
- Status
- completed